Liquid biopsy is rapidly gaining traction for potentially revolutionizing cancer diagnosis and treatment through blood-based utilization of shed biomolecules. This approach can provide a global picture of the cancer in real time, at multiple time points, and with minimal invasiveness. In this review, we familiarize cancer biobanks with the principles used for liquid biopsy work and highlight unique aspects of applying liquid biopsy approaches to pediatric cancers to enable high-quality and efficient translational research.
Get full access to this article
View all access options for this article.
References
1.
SiravegnaG, MarsoniS, SienaS, BardelliA. Integrating liquid biopsies into the management of cancer. Nat Rev Clin Oncol, 2017; 14:531–548.
2.
MerkerJD, OxnardGR, ComptonC, et al.Circulating tumor DNA analysis in patients with cancer: American society of clinical oncology and college of American pathologists joint review. J Clin Oncol, 2018; 36:1631–1641.
3.
RossiG, IgnatiadisM. Promises and pitfalls of using liquid biopsy for precision medicine. Cancer Res, 2019; 79:2798–2804.
4.
BettegowdaC, SausenM, LearyRJ, et al.Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med, 2014; 6:224ra24.
5.
KlegaK, Imamovic-TucoA, HaG, et al.Detection of somatic structural variants enables quantification and characterization of circulating tumor DNA in children with solid tumors. JCO Precis Oncol, 2018; 2018:1–13.
TriggRM, ShawJA, TurnerSD. Opportunities and challenges of circulating biomarkers in neuroblastoma. Open Biol, 2019; 9:190056.
8.
TriggRM, TurnerSD, ShawJA, JahangiriL. Diagnostic accuracy of circulating-free DNA for the determination of MYCN amplification status in advanced-stage neuroblastoma: A systematic review and meta-analysis. Br J Cancer, 2020; 122:1077–1084.
9.
ShulmanDS, KlegaK, Imamovic-TucoA, et al.Detection of circulating tumor DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: A report from the Children's Oncology Group. Br J Cancer, 2018; 119:615–621.
10.
Kahana-EdwinS, McCowageG, CainL, et al.Exploration of CTNNB1 ctDNA as a putative biomarker for hepatoblastoma. Pediatr Blood Cancer, 2020; 67:e28594.
11.
EspositoMR, AveicS, SeydelA, ToniniGP. Neuroblastoma treatment in the post-genomic era. J Biomed Sci, 2017; 24:1–16.
12.
LonerganGJ, SchwabCM, SuarezES, CarlsonCL. From the archives of the AFIP - Neuroblastoma, ganglioneuroblastoma, and ganglioneuroma: Radiologic-pathologic correlation. Radiographics, 2002; 22:911–934.
13.
LommenK, OdehS, de TheijeCC, SmitsKM. Biobanking in molecular biomarker research for the early detection of cancer. Cancers (Basel), 2020; 12:776.
14.
NeumannMHD, BenderS, KrahnT, SchlangeT. ctDNA and CTCs in liquid biopsy – current status and where we need to progress. Comput Struct Biotechnol J, 2018; 16:190–195.
15.
GrölzD, HauchS, SchlumpbergerM, et al.Liquid biopsy preservation solutions for standardized pre-analytical workflows—venous whole blood and plasma. Curr Pathobiol Rep, 2018; 6:275–286.
16.
ChanAKC, YeungS-W, Wing-BongL, RainerTH, LoDYM. Effects of preanalytical factors on the molecular size of cell-free DNA in blood. Clin Chem, 2005; 51:781–784.
17.
RisbergB, TsuiDWY, BiggsH, et al.Effects of collection and processing procedures on plasma circulating cell-free DNA from cancer patients. J Mol Diagn, 2018; 20:883–892.
18.
LodriniM, SprüsselA, AstrahantseffK, et al.Using droplet digital PCR to analyze MYCN and ALK copy number in plasma from patients with neuroblastoma. Oncotarget, 2017; 8:85234–85251.
19.
AllardWJ, MateraJ, MillerMC, et al.Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res, 2004; 10:6897–6904.
20.
Rodriguez-LeeM, KolatkarA, LuttgenMMC, et al.Effect of blood collection tube type and time to processing on the enumeration and high-content characterization of circulating tumor cells using the high-definition single-cell assay. Arch Pathol Lab Med, 2018; 142:198–207.
21.
LukAWS, MaY, DingPN, et al.CTC-mRNA (AR-V7) analysis from blood samples—impact of blood collection tube and storage time. Int J Mol Sci, 2017; 18:1–11.
22.
ZavridouM, MastorakiS, StratiA, TzanikouE, ChimonidouM, LianidouE. Evaluation of preanalytical conditions and implementation of quality control steps for reliable gene expression and DNA methylation analyses in liquid biopsies. Clin Chem, 2018; 64:1522–1533.
23.
Alix-panabiC, BartkowiakK, PantelK. ScienceDirect Functional studies on circulating and disseminated tumor cells in carcinoma patients 5 2016;0–6.
24.
DagurPK, McCoyJP. Collection, storage, and preparation of human blood cells. Curr Protoc Cytom, 2015; 2015:5.1.1–5.1.16.
25.
LuD, GrafRP, HarveyM, et al.Detection and characterization of circulating tumor cells from frozen peripheral blood mononuclear cells. J Circ Biomark, 2015; 4:4.
